Saturday, October 03, 2020 10:09:28 PM
It had cash of $67K at 30 June 2020.
The company spent $3.5m last year, of which $180K was classified as R&D, the balance was on administration expenses, salaries and rent.
Nathanielz has awarded himself salary increase and bonuses for “accomplishments achieved”. Most recent bonus was awarded on 13 July 2020.
Stock price has declined 99.8% in the last 12 months.
The company makes a 9.5% contribution to Nathanielz pension fund.
The company pays rent of $140K for a 5 year lease to a separate company owned by Nathanielz and his wife.
The company employs Nathanielzs’ wife and pays her $120K per year.
The company has litigation pending from claimants alleging they are owed money for services provided.
The company states it is developing novel cancer therapeutics, which is what it has been stating since 2007.
Caveat emptor.
Recent PPCB News
- Biopharma on a Tear After Certificate of Grant from Japanese Patent Office • AllPennyStocks.com • 06/25/2024 04:26:00 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM